Log in

Relevant bibliographies by topics / Cyclophosphamide

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Cyclophosphamide'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cyclophosphamide.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cyclophosphamide"

1

&NA;. "Cyclophosphamide see Busulfan/cyclophosphamide." Reactions Weekly &NA;, no. 369 (1991): 7. http://dx.doi.org/10.2165/00128415-199103690-00025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

&NA;. "Cyclophosphamide see Busulfan/cyclophosphamide." Reactions Weekly &NA;, no. 375 (1991): 6. http://dx.doi.org/10.2165/00128415-199103750-00027.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

&NA;. "Cyclophosphamide see Carboplatin/cyclophosphamide." Reactions Weekly &NA;, no. 380 (1991): 4. http://dx.doi.org/10.2165/00128415-199103800-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

&NA;. "Cyclophosphamide see Indomethacin/cyclophosphamide." Reactions Weekly &NA;, no. 283 (1990): 4. http://dx.doi.org/10.2165/00128415-199002830-00011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

&NA;. "Cyclophosphamide see Busulfan/cyclophosphamide." Reactions Weekly &NA;, no. 324 (1990): 4. http://dx.doi.org/10.2165/00128415-199003240-00014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

&NA;. "Cyclophosphamide see Prednisone/cyclophosphamide." Reactions Weekly &NA;, no. 343 (1991): 4. http://dx.doi.org/10.2165/00128415-199103430-00018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

&NA;. "Cyclophosphamide see Busulfan/cyclophosphamide." Reactions Weekly &NA;, no. 358 (1991): 7. http://dx.doi.org/10.2165/00128415-199103580-00028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Mirazi, Naser, Aida Shahabi Baher, Zahra Izadi, Alireza Nourian, and Samaneh Safari. "Study of Protective Effects of Calendula Officinalis L. Hydrethanolic Extract on Blood Parameters in Wistar Rats Treated With Cyclophosphamide." Qom Univ Med Sci J 15, no. 11 (2022): 744–55. http://dx.doi.org/10.32598/qums.15.11.1757.3.

Full text

Abstract:

Background and Objectives: Some of drugs which used in chemotherapy have destructive effects on hemopoetic tissue. Cyclophosphamid is a drug for malignant cancers treatment with subversion effects on blood hemopoetic bone marrow. Medicinal plants with antioxidant effects have anti-inflammatory and protective effects on bone marrow tissue. The aim of this study is to investigate of protective effect of Calendula officinalis L. hydrethanolic extract (CHE) on boold parameters in Wistar male rats induced with cyclophosphamide. Methods: In this experimental study 35 male Wistar rats (200-220 g) wer

APA, Harvard, Vancouver, ISO, and other styles

9

Elsisy, Rasha A., Medhat Taha, Hany M. A. Sonpol, Turki A. S. Baokbah, Mona A. Abdelkareem, and Amira E. Farage. "Acute effect of cyclophosphamide on rat’s urinary bladder and the possible protective role of sulforaphane: a histological and ultrastructural study." International Journal of Scientific Reports 7, no. 4 (2021): 207. http://dx.doi.org/10.18203/issn.2454-2156.intjscirep20211036.

Full text

Abstract:

<p><strong>Background:</strong> Cyclophosphamide disturbs the oxidant and antioxidant balance that is associated with several unwanted toxic effects and induction of secondary cancers. The aim of this study was to test the protective effects of Sulforaphane on the cyclophosphamide toxicity of rat urinary bladder.</p><p><strong>Methods:</strong> 32 male albino rats were divided into 4 groups, 8 animal each (n=8). Group I received saline intra-peritoneal, group II received 5 mg/kg sulforaphane for 5 days and then saline, group III received 0.9% saline in

APA, Harvard, Vancouver, ISO, and other styles

10

&NA;. "Cyclophosphamide see Chlorambucil/cyclophosphamide/methotrexate." Reactions Weekly &NA;, no. 348 (1991): 7. http://dx.doi.org/10.2165/00128415-199103480-00024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Cyclophosphamide"

1

Levy, Karine. "Toxicité du cyclophosphamide." Paris 5, 1993. http://www.theses.fr/1993PA05P156.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Afsharian, Parvaneh. "Optimization of cyclophosphamide therapy based on pharmacogenetics /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-997-1/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Yule, S. M. "The clinical pharmacology of cyclophosphamide in children." Thesis, University of Newcastle Upon Tyne, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.309831.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Chanellière, Christiane. "Intérêt de l'utilisation du cyclophosphamide dans le traitement des pemphigoi͏̈des bulleuses et des pemphigus." Montpellier 1, 1989. http://www.theses.fr/1989MON11064.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Belfayol-Pisanté, Laurence. "Evaluation d'un index prédictif de l'apparition des effets secondaires liés au traitement par le cyclophosphamide chez des patients atteints de vascularites et de collagénoses." Paris 5, 2000. http://www.theses.fr/2000PA05P629.

Full text

Abstract:

Le cyclophosphamide est un agent anticancéreux et immunosuppresseur utilisé aussi bien dans le traitement des affections malignes que des maladies systémiques. Si les études pharmacocinétiques ont été largement décrites chez les patients traités par le cyclophosphamide seul ou en association pour ses propriétés antinéoplasiques, aucune n'aborde la pharmacocinétique du cyclophosphamide et de son métabolite, le 4-hydroxycyclophosphamide/aldophosphamide, chez les patients atteints de vascularites ou de collagénoses. En raison de la toxicité liée au traitement par le cyclophosphamide chez ces suje

APA, Harvard, Vancouver, ISO, and other styles

6

Lo, Kwun-hang Kenny. "Effects of cyclophosphamide on ulcer in rat stomachs /." View the Table of Contents & Abstract, 2004. http://sunzi.lib.hku.hk/hkuto/record/B30708825.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

盧冠恆 and Kwun-hang Kenny Lo. "Effects of cyclophosphamide on ulcer in rat stomachs." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B45010158.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Maynard-Faure, Patricia. "Synthèse d'analogues bicycliques préactives du cyclophosphamide et de l'aldophosphamide." Lyon 1, 1997. http://www.theses.fr/1997LYO10268.

Full text

Abstract:

Ce memoire de these concerne l'etude de voies de synthese de nouveaux analogues du cyclophosphamide et de l'aldophosphamide. Apres avoir rappele la place du cyclophosphamide, agent cancerostatique le plus utilise en clinique humaine, dans l'arsenal des medicaments anticancereux, nous avons passe en revue les nombreux analogues deja synthetises en vue d'obtenir des composes a index therapeutique plus eleve. Nous presentons ensuite des voies de syntheses possibles pour des derives bicycliques preactives cibles ne necessitant pas d'activation biologique. Ce travail a permis de completer l'etude d

APA, Harvard, Vancouver, ISO, and other styles

9

Lu, Hong. "Pharmacokinetic and drug metabolism studies of cyclophosphamide and ifosfamide /." The Ohio State University, 1998. http://rave.ohiolink.edu/etdc/view?acc_num=osu148795015360318.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Li, Zhaoyang. "DNA alkylation by active metabolites of Cyclophosphamide and Ifosfamide /." The Ohio State University, 1999. http://rave.ohiolink.edu/etdc/view?acc_num=osu1488192960169091.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Cyclophosphamide"

1

Boche, Gernot. Cyclopropane derived reactive intermediates. Wiley, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

R, Nowrousian M., ed. Ifosfamide in cancer therapy: A comparison with cyclophosphamide. Universitätsverlag, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Asli-Yalfani, Esmael. Cellular and molecular studies of the immunopharmacology of cyclophosphamide. University of Manchester, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Azria, M. (Moïse). Calcitonins: Physiological and pharmacological aspects. Springer Verlag, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Lewtas, Joellen. Final report on the evaluation of four toxic chemicals in an In Vivo/In Vitro toxicological screen--acrylamide, chlordecone, cyclophosphamide, and diethylstilbestrol. U.S. Environmental Protection Agency, Health Effects Research Laboratory, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Lundbeck, Finn. The normal mouse urinary bladder reservoir function evaluated by repeated cystometries: Early and late changes after irradiation alone and irradiation combined with cis-diaminedichloroplatinum (II) or cyclophosphamide. Distributed by Scandinavian University Press, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Gutenberg-Universität, Johannes, ed. Untersuchungen zur posttranslationalen Modifikation von Cytochrom P450 2B1 und deren Konsequenzen für die Aktivierung von Cyclophosphamid. [s.n.], 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Renk-Gees, Annemarie. Untersuchungen über den Gehalt an Adeninribonukleotiden und die Zellzahl von Mäuseembryonen in der Präimplantationsphase nach Behandlung mit Cyclophosphamid (Endoxan R). [s.n.], 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Karakas, Tunca. Therapie hochmaligner Non-Hodgkin-Lymphome: Eine Phase-II-Studie mit Vincristin, Adriamycin, Cyclophosphamid, Prednison und Etoposid (VACPE) sowie randomisiert rhGM-CSF. [s.n.], 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Blokdijk, G. J. Cyclophosphamide; The Ultimate Step-By-Step Guide. CreateSpace Independent Publishing Platform, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Cyclophosphamide"

1

Maxwell, Robert A., and Shohreh B. Eckhardt. "Cyclophosphamide." In Drug Discovery. Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-0469-5_20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Mader, Ines, Patrizia Fürst-Weger, Robert Mader, Elisabeth Nogler-Semenitz, and Sabine Wassertheurer. "Cyclophosphamide." In Extravasation of Cytotoxic Agents. Springer Vienna, 2010. http://dx.doi.org/10.1007/978-3-211-88893-3_22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Schwab, Manfred. "Cyclophosphamide." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27841-9_1439-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Bartlett, R. R. "Cyclophosphamide." In Handbook of Experimental Pharmacology. Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73217-1_20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Scorer, Matthew, Olga Golberg, and Karen Harman. "Cyclophosphamide." In Handbook of Systemic Drug Treatment in Dermatology, 3rd ed. CRC Press, 2022. http://dx.doi.org/10.1201/9781003016786-16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Curtis, John J. "Cyclophosphamide." In Immunotherapy in Transplantation. Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781444355628.ch19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Mader, Ines, Patrizia E. Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola, and Sabine M. Wassertheurer. "Cyclophosphamide." In Extravasation of Cytotoxic Agents. Springer Vienna, 2003. http://dx.doi.org/10.1007/978-3-7091-3710-9_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

de Groot, Anton C. "Cyclophosphamide." In Monographs In Contact Allergy. CRC Press, 2022. http://dx.doi.org/10.1201/9781003158004-160.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Neumann, Ron. "Cyclophosphamide." In Intraocular Inflammation. Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-540-75387-2_24.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Saxena, Ajit Kumar, and Amit Kumar. "Introduction of Cyclophosphamide." In Fish Analysis for Drug and Chemicals Mediated Cellular Toxicity. Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-4700-3_1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Cyclophosphamide"

1

Xie, Kening, Mingguo Sun, Shang Qingman Xin, Wei Zhang, and Shengxue Zhou. "Regulation of cyclophosphamide-induced immune activity in mice by arabinogalactan." In 2024 International Conference on Future of Medicine and Biological Information Engineering (MBIE 2024), edited by Yudong Yao, Xiaoou Li, and Xia Yu. SPIE, 2024. http://dx.doi.org/10.1117/12.3038782.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Lichtenfels, Martina, Vivian Fontana, Francine Hickmann Nyland, et al. "What happens in residual disease after neoadjuvant chemotherapy? Efficacy of a novel in vitro breast cancer chemoresistance platform to demonstrate high resistance to drugs." In Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1010.

Full text

Abstract:

Objective: Our preliminary study aimed to validate the efficacy of a novel in vitro chemoresistance platform to demonstrate tumor resistance in residual disease after neoadjuvant treatment for breast cancer. Methodology: Patients with invasive BC who presented residual disease after neoadjuvant chemotherapy (NACT) were included. Fresh tumor samples were collected during surgery and dissociated to obtain the tumor cells. The tumor cells were cultured in the chemoresistance platform with doxorubicin, epirubicin, paclitaxel, docetaxel, and cyclophosphamide, and after 72 h, cell viability was eval

APA, Harvard, Vancouver, ISO, and other styles

3

Kobrová, Kateřina, Lenka Minxová, Jakub Zieg, Sylva Skálová, and Pavla Doležalová. "AB0998 SEVERE IGA VASCULITIS: CYCLOPHOSPHAMIDE IN QUESTION." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.6731.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Ertenli, Ý., V. Cobankara, S. Apras, S. Kiraz, MA Oztürk, and M. Çalgüneri. "AB0079 Cyclophosphamide exposure during pregnancy: two cases." In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.124.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

VIEIRA, ADAH SOPHIA RODRIGUES, GUILHERME LOPES PEREIRA, ANTÔNIO JOSÉ DA SILVA NETO, ALINE DE CASTRO CARACAS, RODRIGO BARBOSA DE AZEVEDO, and REJANE MARIA RODRIGUES DE ABREU VIEIRA. "RITUXIMAB IN POLYARTERITIS CYCLOPHOSPHAMIDE INTOLERANT NODOSE: CASE REPORT." In 36º Congresso Brasileiro de Reumatologia. Editora Blucher, 2019. http://dx.doi.org/10.5151/sbr2019-231.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Saadoun, D., G. Maalouf, M. Vieira, et al. "OP0123 INFLIXIMAB VERSUS CYCLOPHOSPHAMIDE FOR SEVERE BEHÇET’S SYNDROME." In EULAR 2024 European Congress of Rheumatology, 12-15 June. Vienna, Austria. BMJ Publishing Group Ltd and European League Against Rheumatism, 2024. http://dx.doi.org/10.1136/annrheumdis-2024-eular.5027.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Lodh, A., S. Blankenship, J. M. Minish-Pron, and G. M. Solomon. "Cyclophosphamide in the Treatment of Shrinking Lung Syndrome." In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a1985.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Tanaka, N., A. Hirano, H. Inoue, et al. "Abstract OT1-01-02: A phase II trial of neoadjuvant docetaxel/cyclophosphamide followed by epirubicin/cyclophosphamide for triple-negative breast cancer." In Abstracts: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.sabcs16-ot1-01-02.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Robin, P., JM Bernadou, A. Gbologan, et al. "3PC-035 The stability of cyclophosphamide (CPA) and mesna mixture is shortened by cyclophosphamide instability causing quick PH decrease in solution." In 29th EAHP Congress, Copenhagen, Denmark, 12-13-14 March 2025, Person centred pharmacy — Navigating digital health. British Medical Journal Publishing Group, 2025. https://doi.org/10.1136/ejhpharm-2025-eahp.67.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Constantin, Mirela Alina, Lucian Alexandru Constantin, Nicolae Ionut Cristea, and Ines Nitoi. "INFLUENCE OF TiO2 DOPANT TYPE UPON CYCLOPHOSPHAMIDE DEGRADATION EFFICIENCY." In International Symposium "The Environment and the Industry". National Research and Development Institute for Industrial Ecology, 2017. http://dx.doi.org/10.21698/simi.2017.0003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Cyclophosphamide"

1

Yin, Xietian, Shichao Zhao, Nan Xiang, Jidong Chen, Jun Xu, and Yudan Zhang. Efficacy and Safety of Chinese Herbal Medicines combined with Cyclophosphamide for Connective Tissue Disease-Associated Interstitial Lung Disease: A Meta-Analysis of Randomized Controlled Trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.12.0010.

Full text

Abstract:

Review question / Objective: To evaluate the effectiveness and safety of Chinese herbal medicines (CHMs) combined with cyclophosphamide (CTX) for connective tissue disease-associated interstitial lung disease (CTD-ILD) by performing a meta-analysis. Condition being studied: Chinese herbal medicines (CHMs) and cyclophosphamide (CTX) are widely used in the treatment of connective tissue disease-associated interstitial lung disease (CTD-ILD). However, the clinical benefits of CHMs treatment for CTD-ILD are still controversial, and there is no systemic review to summarize and evaluate their effica

APA, Harvard, Vancouver, ISO, and other styles

2

Lao, Lixing, and Richard H. Wong. The Effect of Electroacupuncture on Cyclophosphamide-Induced Emesis in Ferrets. Defense Technical Information Center, 1995. http://dx.doi.org/10.21236/ada299200.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Zhang, LiBo, GuangZhen Liu, and YanChuang Liang. Meta analysis of traditional Chinese medicine combined with cyclophosphamide in the treatment of adult refractory nephrotic syndrome. International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.5.0020.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Emens, Leisha A., and Elizabeth M. Jaffee. Enhancement of an Allogeneic GM-CSF-Secreting Breast Cancer Vaccine by Immunomodulatory Doses of Cyclophosphamide and Doxorubicin. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada417167.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!